HK141494A - Peptide fragments of HIV - Google Patents
Peptide fragments of HIVInfo
- Publication number
- HK141494A HK141494A HK141494A HK141494A HK141494A HK 141494 A HK141494 A HK 141494A HK 141494 A HK141494 A HK 141494A HK 141494 A HK141494 A HK 141494A HK 141494 A HK141494 A HK 141494A
- Authority
- HK
- Hong Kong
- Prior art keywords
- proline
- hiv
- peptide
- isoleucine
- fragment
- Prior art date
Links
- 108010033276 Peptide Fragments Proteins 0.000 title 1
- 102000007079 Peptide Fragments Human genes 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898918200A GB8918200D0 (en) | 1989-08-09 | 1989-08-09 | The peptide fragments of hiv |
| PCT/GB1990/001230 WO1991001996A1 (en) | 1989-08-09 | 1990-08-07 | Peptide fragments of hiv |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK141494A true HK141494A (en) | 1994-12-23 |
Family
ID=43806939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK141494A HK141494A (en) | 1989-08-09 | 1994-12-15 | Peptide fragments of HIV |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5700635A (da) |
| EP (1) | EP0412766B1 (da) |
| JP (1) | JPH04507100A (da) |
| AT (1) | ATE103294T1 (da) |
| CA (1) | CA2064691A1 (da) |
| DE (1) | DE69007571T2 (da) |
| DK (1) | DK0412766T3 (da) |
| ES (1) | ES2054256T3 (da) |
| GB (2) | GB8918200D0 (da) |
| HK (1) | HK141494A (da) |
| SG (1) | SG130094G (da) |
| WO (1) | WO1991001996A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6210873B1 (en) | 1987-08-28 | 2001-04-03 | Board Of Regents, The University Of Texas System | Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
| US5128319A (en) | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
| ATE134195T1 (de) * | 1988-06-10 | 1996-02-15 | United Biomedical Inc | Peptidfragmente von hiv |
| CA2072351A1 (en) * | 1990-01-05 | 1991-07-06 | Andrew J. Mcmichael | Hiv-1 core protein fragments |
| US5603933A (en) * | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
| WO1995011255A1 (fr) * | 1993-10-19 | 1995-04-27 | Ajinomoto Co., Inc. | Peptide pouvant induire une reponse immune contre vih et agent contenant ce peptide pour la prevention ou le traitement du sida |
| GB9426153D0 (en) * | 1994-12-23 | 1995-02-22 | Medical Res Council | Improvements in or relating to vaccines |
| CA2392877C (en) * | 1999-12-23 | 2011-11-15 | Tomas Hanke | Improvements in or relating to immune responses to hiv |
| CU23235A1 (es) * | 2001-02-28 | 2007-09-26 | Ct Ingenieria Genetica Biotech | POXVIRUS RECOMBINANTES PARA PROTEINAS QUIMéRICAS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA Y SU APLICACION EN LA TERAPéUTICA Y LA PREVENCION DEL SIDA |
| NZ588445A (en) * | 2008-04-24 | 2013-03-28 | Avery Dennison Corp | Sheet having labels with adhesive removable from liner with weakened line on liner having linear portions and apices so as to fold about linear portions |
| EP2620446A1 (en) | 2012-01-27 | 2013-07-31 | Laboratorios Del Dr. Esteve, S.A. | Immunogens for HIV vaccination |
| EP4058058A1 (en) | 2019-11-14 | 2022-09-21 | Aelix Therapeutics S.L. | Dosage regimens for vaccines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6713287A (en) * | 1986-01-06 | 1987-07-09 | F. Hoffmann-La Roche & Co. | Expression of htlv-iii gag-gene |
| NO881151L (no) * | 1987-03-27 | 1988-09-28 | Syntello Ab | Syntetisk hiv-1-antigen. |
| EP0330359A3 (en) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Composition useful in the diagnosis and treating of hiv-1 infection |
-
1989
- 1989-08-09 GB GB898918200A patent/GB8918200D0/en active Pending
-
1990
- 1990-08-07 GB GB9201468A patent/GB2250994B/en not_active Expired - Fee Related
- 1990-08-07 AT AT90308662T patent/ATE103294T1/de not_active IP Right Cessation
- 1990-08-07 WO PCT/GB1990/001230 patent/WO1991001996A1/en active Application Filing
- 1990-08-07 DK DK90308662.7T patent/DK0412766T3/da active
- 1990-08-07 CA CA002064691A patent/CA2064691A1/en not_active Abandoned
- 1990-08-07 JP JP2511801A patent/JPH04507100A/ja active Pending
- 1990-08-07 EP EP90308662A patent/EP0412766B1/en not_active Revoked
- 1990-08-07 DE DE69007571T patent/DE69007571T2/de not_active Revoked
- 1990-08-07 ES ES90308662T patent/ES2054256T3/es not_active Expired - Lifetime
-
1994
- 1994-09-06 SG SG130094A patent/SG130094G/en unknown
- 1994-12-15 HK HK141494A patent/HK141494A/xx not_active IP Right Cessation
- 1994-12-19 US US08/359,000 patent/US5700635A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0412766B1 (en) | 1994-03-23 |
| JPH04507100A (ja) | 1992-12-10 |
| GB2250994B (en) | 1993-08-25 |
| US5700635A (en) | 1997-12-23 |
| DE69007571T2 (de) | 1994-09-08 |
| WO1991001996A1 (en) | 1991-02-21 |
| GB2250994A (en) | 1992-06-24 |
| GB9201468D0 (en) | 1992-04-01 |
| EP0412766A1 (en) | 1991-02-13 |
| ES2054256T3 (es) | 1994-08-01 |
| GB8918200D0 (en) | 1989-09-20 |
| CA2064691A1 (en) | 1991-02-10 |
| SG130094G (en) | 1995-01-13 |
| ATE103294T1 (de) | 1994-04-15 |
| DK0412766T3 (da) | 1994-07-18 |
| DE69007571D1 (de) | 1994-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2255093A (en) | Hiv-1 core protein fragments | |
| HK1053662A1 (en) | Gag antigen and its use for the detection of lav infection and in immunogenic compositions | |
| FI950405A0 (fi) | Heikosti immunogeenisten antigeenien ja synteettisten peptidikantajien konjugaatit sekä niitä sisältävät rokotteet | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| GB8912651D0 (en) | Peptide fragments of hiv | |
| GB2250994B (en) | Peptide fragments of hiv | |
| WO1989002277A3 (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
| SG63621A1 (en) | Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines | |
| HUP9904171A2 (hu) | A ragadós száj- és körömfájás vírusok immunogén peptidjei | |
| NZ224251A (en) | Synthetic rhinovirus (hrv) peptides and vaccines | |
| ES2071038T3 (es) | Peptidos asociados al hiv. | |
| ATE111485T1 (de) | Peptidbehandlung von hartnäckigen infektionskrankheiten. | |
| ES2061944T3 (es) | Conjugado de peptido inmunologicamente activo ppd (nanp)n util como vacuna antimalaria. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |